Managers / Q1 2022 · view latest →
Weaver C. Barksdale & Associates, Inc.
CIK 0001294588 · 40 BURTON HILLS BLVD., SUITE 230, NASHVILLE, TN, 37215 · 615-665-1085
Summary
Weaver C. Barksdale & Associates, Inc. reported $112M in U.S.-listed holdings across 61 positions for Q1 2022.
Its largest position, ABBV, represents 2.6% of the portfolio.
Compared with Q4 2021, the fund opened 2 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.2% · $107M
- REIT · 3.4% · $4M
- Other · 1.4% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| EOGEOG RES INC | NEW | +18.0K | 18.0K | +$2M | $2M |
| TRPTC ENERGY CORP | NEW | +35.4K | 35.4K | +$2M | $2M |
| MPCMARATHON PETE CORP | TRIMMED | −21.2K | 13.2K | −$1M | $1M |
| CHVCHEVRON CORP NEW | TRIMMED | −4.4K | 13.5K | +$100,000 | $2M |
| LMTLOCKHEED MARTIN CORP | TRIMMED | −666 | 4.2K | +$127,000 | $2M |
| CVSCVS HEALTH CORP | TRIMMED | −2.9K | 19.6K | −$335,000 | $2M |
| TDTORONTO DOMINION BK ONT | TRIMMED | −1.8K | 28.3K | −$64,000 | $2M |
| A4SAMERIPRISE FINL INC | TRIMMED | −433 | 7.2K | −$140,000 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $105M | 62 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $95M | 62 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 62 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 62 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $104M | 62 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $104M | 62 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $111M | 62 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $105M | 62 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $109M | 62 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $102M | 62 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $117M | 62 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $101M | 62 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $107M | 62 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $113M | 62 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $100M | 63 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $107M | 63 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $112M | 61 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $110M | 59 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.